PT  - JOURNAL ARTICLE
AU  - Lu Xiao-Jie
AU  - Gao Ai-Mei
AU  - Ji Li-Juan
AU  - Xu Jiang
TI  - Pseudogene in cancer: real functions and promising signature
AID  - 10.1136/jmedgenet-2014-102785
DP  - 2015 Jan 01
TA  - Journal of Medical Genetics
PG  - 17--24
VI  - 52
IP  - 1
4099  - http://jmg.bmj.com/content/52/1/17.short
4100  - http://jmg.bmj.com/content/52/1/17.full
SO  - J Med Genet2015 Jan 01; 52
AB  - Pseudogenes were initially regarded as non-functional genomic fossils resulted from inactivating gene mutations during evolution. However, later studies revealed that they play a plethora of roles at multiple levels (DNA, RNA and/or protein) in diverse physiological and pathological processes, especially in cancer, both parental-gene-dependently and parental-gene-independently. Pseudogenes can interact with parental genes or other gene loci, leading to alteration in their sequences and/or transcriptional activities. Pseudogene-derived RNAs play multifaceted roles in post-transcriptional regulation as antisense RNAs, endogenous small-interference RNAs, competing endogenous RNAs and so on. Pseudogenic proteins can mirror, mimic or interfere with the functions of their parental counterparts. Herein, we discuss the general aspects (origination, classification, identification) of pseudogenes, focus on their multiple functions in cancer pathogenesis and prospect the potentials they hold as molecular signatures assisting in cancer reclassification and tailored therapy.